NCT06441682 - A Safety and Efficacy Study of ARGX-119 in Adult Patients with Amyotrophic Lateral Sclerosis (ALS) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 23, 2024

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions

Amyotrophic Lateral Sclerosis

Interventions

BIOLOGICAL

ARGX-119

Intravenous infusion of ARGX-119

OTHER

Placebo

Intravenous infusion of placebo

Trial Locations (9)

RECRUITING

Bispebjerg University Hospital, Copenhagen

RECRUITING

UZ Leuven, Leuven

RECRUITING

Aarhus Universitets Hospital, Aarhus

RECRUITING

Kaye Edmonton Clinic, Edmonton

RECRUITING

CHU Bretonneau, Tours

RECRUITING

Hôpital La Pitié Salpêtrière, Paris

RECRUITING

Montreal Neurological Institute and Hospital, Montreal

RECRUITING

UMC Utrecht, Utrecht

RECRUITING

Akademiskt specialistcentrum Karolinska Institutet, Stockholm